 Neelanjan Mukherjee
Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 13 | 2023 | 388 | 2.380 |
Why?
| | RNA, Messenger | 15 | 2024 | 2676 | 1.760 |
Why?
| | RNA | 8 | 2023 | 883 | 1.550 |
Why?
| | Transcriptome | 7 | 2021 | 883 | 1.130 |
Why?
| | Polyadenylation | 3 | 2024 | 40 | 0.960 |
Why?
| | Pteridines | 1 | 2023 | 22 | 0.840 |
Why?
| | Gene Expression Regulation | 8 | 2025 | 2508 | 0.840 |
Why?
| | Aldehydes | 1 | 2023 | 138 | 0.790 |
Why?
| | Aldosterone | 1 | 2021 | 42 | 0.750 |
Why?
| | Evolution, Molecular | 3 | 2024 | 467 | 0.740 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 132 | 0.720 |
Why?
| | RNA, Ribosomal | 1 | 2021 | 162 | 0.700 |
Why?
| | Ribonucleoproteins | 3 | 2019 | 87 | 0.690 |
Why?
| | ELAV-Like Protein 1 | 6 | 2021 | 16 | 0.620 |
Why?
| | Antigens, Surface | 3 | 2011 | 150 | 0.520 |
Why?
| | HEK293 Cells | 8 | 2019 | 687 | 0.510 |
Why?
| | RNA, Untranslated | 1 | 2016 | 114 | 0.490 |
Why?
| | Tristetraprolin | 1 | 2014 | 5 | 0.450 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 2011 | 87 | 0.430 |
Why?
| | Gene Expression Profiling | 5 | 2016 | 1689 | 0.420 |
Why?
| | Sequence Analysis, RNA | 6 | 2019 | 428 | 0.410 |
Why?
| | RNA Stability | 1 | 2011 | 100 | 0.350 |
Why?
| | Binding Sites | 6 | 2019 | 1241 | 0.340 |
Why?
| | RNA Precursors | 1 | 2011 | 147 | 0.340 |
Why?
| | MicroRNAs | 6 | 2019 | 677 | 0.300 |
Why?
| | Computational Biology | 4 | 2018 | 598 | 0.250 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1098 | 0.240 |
Why?
| | Estrous Cycle | 1 | 2025 | 21 | 0.240 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2024 | 22 | 0.230 |
Why?
| | Ovary | 2 | 2025 | 214 | 0.230 |
Why?
| | Poly A | 1 | 2024 | 48 | 0.230 |
Why?
| | Giardia lamblia | 1 | 2024 | 23 | 0.230 |
Why?
| | Gene Regulatory Networks | 2 | 2025 | 281 | 0.230 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2024 | 45 | 0.230 |
Why?
| | T-Lymphocytes | 2 | 2009 | 1924 | 0.220 |
Why?
| | Eukaryota | 1 | 2024 | 53 | 0.220 |
Why?
| | Immunoprecipitation | 3 | 2014 | 157 | 0.220 |
Why?
| | Endosomes | 1 | 2024 | 127 | 0.220 |
Why?
| | Follicle Stimulating Hormone | 1 | 2025 | 239 | 0.210 |
Why?
| | ELAV Proteins | 3 | 2011 | 14 | 0.200 |
Why?
| | 3' Untranslated Regions | 2 | 2021 | 140 | 0.190 |
Why?
| | Argonaute Proteins | 2 | 2019 | 28 | 0.180 |
Why?
| | Ribosomes | 2 | 2015 | 164 | 0.180 |
Why?
| | Angiotensin II | 1 | 2021 | 93 | 0.180 |
Why?
| | Phylogeny | 1 | 2024 | 846 | 0.180 |
Why?
| | Molecular Sequence Annotation | 2 | 2019 | 88 | 0.170 |
Why?
| | Software | 3 | 2018 | 610 | 0.170 |
Why?
| | Interferons | 1 | 2021 | 192 | 0.160 |
Why?
| | Herpesvirus 8, Human | 2 | 2011 | 59 | 0.160 |
Why?
| | Open Reading Frames | 2 | 2016 | 116 | 0.160 |
Why?
| | Hydrocortisone | 1 | 2021 | 304 | 0.160 |
Why?
| | Base Sequence | 3 | 2019 | 2135 | 0.160 |
Why?
| | Proteome | 1 | 2023 | 431 | 0.160 |
Why?
| | Nucleotide Motifs | 1 | 2018 | 33 | 0.150 |
Why?
| | Drosophila melanogaster | 2 | 2019 | 217 | 0.150 |
Why?
| | Humans | 23 | 2021 | 129126 | 0.150 |
Why?
| | Gene Expression | 2 | 2016 | 1462 | 0.150 |
Why?
| | RNA Splicing | 2 | 2017 | 262 | 0.150 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 582 | 0.150 |
Why?
| | RNA, Antisense | 2 | 2019 | 15 | 0.150 |
Why?
| | Signal Transduction | 4 | 2024 | 4838 | 0.140 |
Why?
| | Drosophila Proteins | 1 | 2019 | 187 | 0.140 |
Why?
| | DEAD-box RNA Helicases | 1 | 2017 | 65 | 0.130 |
Why?
| | RNA, Long Noncoding | 1 | 2019 | 178 | 0.130 |
Why?
| | Protein Biosynthesis | 3 | 2015 | 397 | 0.130 |
Why?
| | RNA, Viral | 2 | 2011 | 617 | 0.130 |
Why?
| | Cells, Cultured | 2 | 2021 | 4010 | 0.130 |
Why?
| | Neoplasm Proteins | 2 | 2017 | 421 | 0.120 |
Why?
| | DNA Damage | 1 | 2017 | 364 | 0.120 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 571 | 0.120 |
Why?
| | Phenotype | 1 | 2023 | 3058 | 0.120 |
Why?
| | RNA, Plant | 1 | 2013 | 9 | 0.110 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 137 | 0.110 |
Why?
| | Genome, Human | 1 | 2016 | 392 | 0.110 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2010 | 757 | 0.100 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2012 | 20 | 0.100 |
Why?
| | Protein Interaction Mapping | 1 | 2013 | 109 | 0.100 |
Why?
| | Arabidopsis | 1 | 2013 | 81 | 0.100 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2012 | 60 | 0.100 |
Why?
| | Lymphoma, Primary Effusion | 1 | 2011 | 3 | 0.100 |
Why?
| | Nanoparticles | 1 | 2016 | 368 | 0.090 |
Why?
| | Transcription, Genetic | 2 | 2019 | 1403 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1353 | 0.090 |
Why?
| | Amino Acid Motifs | 1 | 2011 | 209 | 0.090 |
Why?
| | Nuclear Factor 90 Proteins | 1 | 2010 | 1 | 0.090 |
Why?
| | Ovarian Neoplasms | 1 | 2016 | 490 | 0.090 |
Why?
| | Poly(A)-Binding Proteins | 1 | 2009 | 4 | 0.080 |
Why?
| | Stilbenes | 1 | 2009 | 37 | 0.080 |
Why?
| | Jurkat Cells | 1 | 2009 | 131 | 0.080 |
Why?
| | Mice | 8 | 2025 | 16644 | 0.080 |
Why?
| | Animals | 12 | 2025 | 34600 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2016 | 2347 | 0.070 |
Why?
| | Thymus Gland | 1 | 2009 | 309 | 0.070 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2007 | 150 | 0.070 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2024 | 357 | 0.060 |
Why?
| | Cell Line, Tumor | 5 | 2016 | 3184 | 0.060 |
Why?
| | Kinetics | 1 | 2009 | 1617 | 0.060 |
Why?
| | Algorithms | 1 | 2013 | 1621 | 0.060 |
Why?
| | rho GTP-Binding Proteins | 1 | 2006 | 62 | 0.060 |
Why?
| | Radiation Tolerance | 1 | 2006 | 97 | 0.060 |
Why?
| | Follicle Stimulating Hormone, beta Subunit | 1 | 2025 | 30 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2017 | 2150 | 0.060 |
Why?
| | Adenoviridae | 1 | 2005 | 190 | 0.060 |
Why?
| | Paclitaxel | 1 | 2005 | 215 | 0.060 |
Why?
| | Neoplasm Invasiveness | 1 | 2006 | 480 | 0.060 |
Why?
| | Protein Binding | 2 | 2024 | 2106 | 0.060 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2005 | 186 | 0.060 |
Why?
| | Molecular Sequence Data | 3 | 2014 | 2819 | 0.060 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 190 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2737 | 0.050 |
Why?
| | Protein Transport | 1 | 2024 | 422 | 0.050 |
Why?
| | RNA Interference | 2 | 2016 | 441 | 0.050 |
Why?
| | Multigene Family | 2 | 2014 | 198 | 0.050 |
Why?
| | Glioblastoma | 1 | 2006 | 322 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 940 | 0.040 |
Why?
| | Substrate Specificity | 2 | 2012 | 367 | 0.040 |
Why?
| | Introns | 1 | 2019 | 249 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2025 | 2765 | 0.040 |
Why?
| | Prostatic Neoplasms | 1 | 2005 | 1013 | 0.040 |
Why?
| | Radiation, Ionizing | 1 | 2017 | 75 | 0.030 |
Why?
| | Brain Neoplasms | 1 | 2006 | 1164 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 2010 | 1044 | 0.030 |
Why?
| | DNA Repair | 1 | 2017 | 205 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2016 | 291 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2017 | 930 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 267 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2014 | 368 | 0.030 |
Why?
| | Female | 5 | 2025 | 68517 | 0.030 |
Why?
| | Plant Roots | 1 | 2013 | 44 | 0.030 |
Why?
| | Systems Integration | 1 | 2013 | 40 | 0.030 |
Why?
| | Gene Expression Regulation, Plant | 1 | 2013 | 57 | 0.030 |
Why?
| | Genome, Plant | 1 | 2013 | 50 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2016 | 326 | 0.030 |
Why?
| | Epigenomics | 1 | 2013 | 111 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2013 | 330 | 0.030 |
Why?
| | Response Elements | 1 | 2012 | 89 | 0.020 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2012 | 61 | 0.020 |
Why?
| | Cross-Linking Reagents | 1 | 2012 | 206 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2013 | 335 | 0.020 |
Why?
| | Signal-To-Noise Ratio | 1 | 2011 | 68 | 0.020 |
Why?
| | Alternative Splicing | 1 | 2013 | 218 | 0.020 |
Why?
| | Macaca | 1 | 2010 | 50 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2014 | 2041 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2011 | 228 | 0.020 |
Why?
| | Operon | 1 | 2010 | 63 | 0.020 |
Why?
| | Regulon | 1 | 2010 | 35 | 0.020 |
Why?
| | Eukaryotic Cells | 1 | 2010 | 34 | 0.020 |
Why?
| | Immunoblotting | 1 | 2010 | 300 | 0.020 |
Why?
| | Receptors, Death Domain | 1 | 2009 | 3 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 374 | 0.020 |
Why?
| | Chromatin | 1 | 2013 | 478 | 0.020 |
Why?
| | Brain | 2 | 2012 | 2628 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 816 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2010 | 379 | 0.020 |
Why?
| | Chemokines | 1 | 2009 | 222 | 0.020 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2007 | 6 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 2007 | 27 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2011 | 485 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3896 | 0.020 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2007 | 40 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2008 | 228 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2007 | 173 | 0.020 |
Why?
| | Species Specificity | 1 | 2008 | 570 | 0.020 |
Why?
| | HeLa Cells | 1 | 2008 | 607 | 0.020 |
Why?
| | Receptor, IGF Type 1 | 1 | 2006 | 66 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2016 | 5284 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3033 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2006 | 251 | 0.020 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2005 | 45 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2009 | 580 | 0.020 |
Why?
| | Stem Cells | 1 | 2009 | 579 | 0.010 |
Why?
| | Caspases | 1 | 2005 | 242 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2006 | 799 | 0.010 |
Why?
| | Saccharomyces cerevisiae | 1 | 2008 | 525 | 0.010 |
Why?
| | Transfection | 1 | 2006 | 896 | 0.010 |
Why?
| | Mice, Nude | 1 | 2005 | 683 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2005 | 293 | 0.010 |
Why?
| | Blotting, Western | 1 | 2006 | 1169 | 0.010 |
Why?
| | ErbB Receptors | 1 | 2006 | 603 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 828 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2007 | 823 | 0.010 |
Why?
| | Mutation | 1 | 2012 | 3700 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2008 | 1192 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2009 | 1901 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1695 | 0.010 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2005 | 750 | 0.010 |
Why?
| | Male | 3 | 2014 | 63201 | 0.010 |
Why?
| | Rats | 1 | 2006 | 5173 | 0.010 |
Why?
| | Apoptosis | 1 | 2005 | 2438 | 0.010 |
Why?
| | Child | 1 | 2012 | 20805 | 0.010 |
Why?
| | Adult | 1 | 2014 | 35512 | 0.010 |
Why?
|
|
Mukherjee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|